Categories: BusinessFinTechHardwareLocalMarketMedTech
PneumRx, Inc. is a medical device company located in Mountain View, California, and Munich, Germany. PneumRx was founded in 2004 with the aim of meeting the significant market need for better, minimally invasive treatments for emphysema patients. The PneumRx RePneu LVRC is CE Marked and commercialised in Europe. In December 2014, PneumRx was acquired by BTG Plc (LSE:BTG) in a deal worth up to $475 million, based on an initial consideration of $230 million and up to $245 million in performance-related milestone payments.
Investors 2
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.01.2011 | Series C | $33M | - |
| 06.03.2007 | - | $27M | - |
Mentions in press and media 7
| Date | Title | Description |
| 31.12.2014 | PneumRx Acquired by BTG for up to $475 Million | Mountain View, CA—December 4, 2014—/PRNewswire/—PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that it has signed an agreement to be acquired by BTG Plc (LSE:BTG) in a deal worth up to ... |
| 04.11.2013 | COPD advances: New focus on biomarkers, genetic analysis and continuous oxygen | Spirometry continues to be an important tool for generating pneumotachographs, which are helpful in assessing COPD. Along with promoting smoking cessation, vaccinations, Alpha-1 testing and exercise, patient health status should be monitore... |
| 04.01.2011 | PneumRx Raises $33M | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
PneumRx, a Mountain View, CA-based maker of a medical device that restores elastic recoil in the damaged lung tissue of patients with emphysema, said today that it has raised ... |
| 04.01.2011 | PneumRx Raises $33M | PneumRx, Inc., a Mountain View, California-based medical device company focused on the development and commercialization of innovative products to treat emphysema using minimally-invasive techniques, has raised $33m in capital.
The round wa... |
| 04.01.2011 | Funding roundup: PneumRx nets $33 million | Here’s a roundup of the latest dealflow and investment news:
PneumRx nets $33 million
PneumRx Inc. raised $33 million in working capital commitments, according to the company. The oversubscribed round was led by Europe-based venture capital... |
| 06.03.2007 | PneumRx, device maker for lung cancer, emphysema, raises $27M | PneumRx, a maker of medical devices that diagnose and treat lung cancer and Chronic Obstructive Pulmonary Disease (COPD, or emphysema), said it has raised a $27 million in a second round of funding.
Adams Street Partners and Telegraph Hill ... |
| - | COPD advances: New focus on biomarkers, genetic analysis and continuous oxygen | Many treatment options exist for patients with chronic obstructive pulmonary disease (COPD). Most of them have historically focused on improving airway obstruction, so the patient can exhale more easily and with less wheezing.
While this is... |
Reviews 0
